Previous Article | Next Article ![]()
Infection and Immunity, December 1999, p. 6314-6320, Vol. 67, No. 12
Unité de
Mycologie1 and Unité
d'Immuno-Allergie,2 Institut Pasteur, 75724 Paris Cedex 15, and Service d'Anatomie et de Cytologie
Pathologiques, Hôpital Raymond Poincaré, 92380 Garches,3 France
Received 28 June 1999/Returned for modification 6 August
1999/Accepted 1 September 1999
Cryptococcosis is an hematogenously disseminated
meningoencephalitis during which the relationship between the disease
severity and the immune response remains unclear. We thus analyzed, by enzyme-linked immunosorbent assay, proinflammatory (tumor necrosis factor alpha [TNF-
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Cytokine Profiles of AIDS Patients Are Similar to Those of Mice
with Disseminated Cryptococcus neoformans
Infection
] and interleukin-6 [IL-6]) and
anti-inflammatory (IL-10) cytokine levels in plasma at the time of
diagnosis in 51 AIDS patients with culture-proven cryptococcosis.
We used a murine model to determine the correlation between cytokine
levels and fungal burden in blood and tissues and the kinetics of the immune response and of the formation of cerebral lesions. In AIDS patients, plasma TNF-
and IL-10, but not IL-6, levels were
significantly higher in the case of fungemia or disseminated
infection than in their absence, whereas the presence of meningitis had
no influence on these levels. In mice, none of these cytokines were
detected within the first day after inoculation. Later on,
TNF-
and IL-10, but not IL-6, levels in plasma correlated
significantly with the fungal burden in the blood and spleen but not
the brain. In the brain, cytokine levels were low compared to those in
other compartments, and tissue lesions and a degree of infection
similar to those observed in humans were seen, further suggesting the
relevance of this experimental model. Thus, AIDS patients with
cryptococcosis produce an immune response that reflects the
dissemination but not the meningeal involvement. This murine model of
disseminated cryptococcosis can be used to investigate the
pathophysiology of cryptococcosis and new therapeutic approaches.
*
Corresponding author. Mailing address: Unité de
Mycologie, Institut Pasteur, 25, rue du Dr.-Roux, 75724 Paris Cedex 15, France. Phone: 33 1 40 61 33 89. Fax: 33 1 45 68 84 20. E-mail:
dromer{at}pasteur.fr.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|